Learn more about investing in Inso Bio

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
Inso Bio
Next-generation sample prep. In Solution
Founded
2018
Employees*
2-10
Website
inso.bio/
* Data source: Crunchbase
Harvey Tian, Ph.D., CEO
"What Inso Bio is helping create is the infrastructure around genomics. We improve the capability for genomics to be utilized in the greater world, for example, in sequencing plants to determine the best crop strains, or in determining the biology of an individual patient for precision medicine purposes."
Changing 7 steps and 4 hours to a single automated step and 40 minutes, for scalable genomic DNA preparation.

The need to process many samples is holding genomics back in all sectors, from personalized genomics to agriculture. Inso Bio simplifies genomics prep into a single, automated, in-solution step (In Solution—get it?), drastically increasing scalability. Even better, our solution is fast, precise, and can be easily applied to Illumina, PacBio, and Oxford Nanopore-based sequencing technologies, increasing access to all genomics-enabling technologies.